6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00566462 (ClinicalTrials.gov)	October 2007	29/11/2007	Assessment of Perampanel(E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study Wit ...	Assessment of Perampanel(E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study Wit ...	Parkinson's Disease	Drug: perampanel;Drug: placebo	Eisai Inc.	NULL	Terminated	30 Years	N/A	All	1	Phase 2	United States
2	NCT00505622 (ClinicalTrials.gov)	July 2007	9/7/2007	Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel(E2007) as an Adjunctive ...	A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effic ...	Parkinson's Disease	Drug: Perampanel	Eisai Limited	NULL	Terminated	30 Years	N/A	All	328	Phase 3	France
3	NCT00368108 (ClinicalTrials.gov)	August 2006	22/8/2006	Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Mo ...	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, ...	Parkinson's Disease	Drug: 2 mg perampanel;Drug: 4 mg perampanel;Drug: placebo comparator	Eisai Inc.	NULL	Completed	30 Years	N/A	All	752	Phase 3	United States;Canada
4	NCT01634360 (ClinicalTrials.gov)	November 2004	3/7/2012	Long-Term Safety, Tolerability and Efficacy in PerampanelTreated Parkinson's Disease Patients With M ...	A 48-month Open Label Multi-centered Extension Study to Evaluate the Long-term Safety, Tolerability ...	Parkinson's Disease	Drug: Perampanel	Eisai Inc.	NULL	Terminated	N/A	N/A	All	185	Phase 2	NULL

First Previous1Next Last